Related Experiment Video
Updated: Jun 18, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical Enterobacter roggenkampii
Suruchi Nepal1, Sandra Maaß2, Stefano Grasso1
1University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, University of Groningen, Hanzeplein 1, P.O. Box 30001, 9700 RB Groningen, The Netherlands.
Abstract:
Gram-negative bacteria belonging to the Enterobacter cloacae complex are increasingly implicated in difficult-to-treat nosocomial infections, as exemplified by a recently characterized highly carbapenem-resistant clinical Enterobacter roggenkampii isolate with sequence type (ST) 232. While mechanisms of carbapenem resistance are well-understood, little is known about the responses of highly drug-resistant bacteria to these antibiotics. Our present study was therefore aimed at charting the responses of the E. roggenkampii ST232 isolate to the carbapenem imipenem, using a 'stable isotope labeling of amino acids in cell culture' approach for quantitative mass spectrometry. This unveiled diverse responses of E. roggenkampii ST232 to imipenem, especially altered levels of proteins for cell wall biogenesis, central carbon metabolism, respiration, iron-sulfur cluster synthesis, and metal homeostasis. These observations suggest a scenario where imipenem-challenged bacteria reduce metabolic activity to save resources otherwise used for cell wall biogenesis, and to limit formation of detrimental reactive oxygen species at the cytoplasmic membrane due to respiration and Fenton chemistry. We consider these observations important, because knowing the adaptive responses of a highly resistant bacterium of the E. cloacae complex to last-resort antibiotics, such as imipenem, provides a 'sneak preview' into the future development of antibiotic resistance in this emerging group of pathogens.
Insights
Highly carbapenem-resistant Enterobacter cloacae complex bacteria, like E. roggenkampii ST232, reduce metabolic activity when treated with imipenem. This response conserves resources and limits damaging reactive oxygen species formation.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- The Enterobacter cloacae complex is a growing cause of hospital-acquired infections.
- A carbapenem-resistant Enterobacter roggenkampii (ST232) highlights the need to understand resistance mechanisms.
- Limited knowledge exists on how highly drug-resistant bacteria respond to antibiotics.
Purpose of the Study:
- To investigate the adaptive responses of E. roggenkampii ST232 to imipenem.
- To identify protein level changes induced by carbapenem exposure.
Main Methods:
- Utilized stable isotope labeling of amino acids in cell culture (SILAC) for quantitative mass spectrometry.
- Analyzed protein expression profiles of E. roggenkampii ST232 in response to imipenem.
Main Results:
- Imipenem treatment induced significant alterations in protein levels.
- Key affected pathways include cell wall biogenesis, central carbon metabolism, and respiration.
- Changes in iron-sulfur cluster synthesis and metal homeostasis were also observed.
Conclusions:
- E. roggenkampii ST232 downregulates metabolic activity under imipenem stress.
- This adaptive strategy conserves resources and mitigates oxidative stress.
- Understanding these responses offers insights into future antibiotic resistance evolution.
More Related Videos
14:06Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Published on: November 12, 2012
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Rapid Identification of Pathogens
Clinical Significance of Antibiotic Resistance